Dong Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dong Jia has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Yizhuo Gao
Shengjing Hospital of China Medical University, Shenyang, China
9 shared publicationsShibo Wei
Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, China
4 shared publicationsYuchen Liu
Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang, Beijing, China
4 shared publicationsNa Wang
Occupational Disease and Occupational Health Prevention and Control Institute Liaoning Center for Disease Control and Prevention Shenyang Liaoning China
3 shared publicationsXuejiao Wei
Department of Public Health Sciences, Queen’s University, Kingston, Canada
3 shared publicationsZhichun Gu
Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in JACC: Asia
Risk Assessment, Prophylaxis, and Treatment Among Hospital-Acquired VTE in China
- 25 September 2026
- Published by Elsevier in JACC: Asia
Open AccessRisk Assessment, Prophylaxis, and Treatment Among Hospital-Acquired VTE in China
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA1372
Ventricular Septum Curvature Ratio: A Novel Imaging Marker to Predict Clinical Deterioration in Normotensive Acute Pulmonary Embolism
Background: Identifying high-probability deterioration individuals at the time of admission remains a challenge in normotensive patients with acute pulmonary embolism (PE). Ventricular septum (VS) deviation, as observed on computed tomography pulmonary angiography (CTPA), has been associated with poor prognosis in acute PE patients. Methods: This prospective multicenter cohort study enrolled normotensive patients with acute PE across five centers in China between January 2021 and June 2024. The VS and left ventricle (LV) free-wall curvature radii were measured using CTPA, and the VS curvature ratio was calculated and categorized. The endpoint was the occurrence of clinical deterioration event within 30 days after admission. The relationship between the VS curvature ratio and deterioration was analyzed using hierarchical logistic regression. The efficacy of identifying deterioration was assessed using the area under the receiver operating characteristic curve (AUC). Results: Of 3,310 patients, 272 (8.2%) experienced deterioration. In 3,030 patients from three centres, VS were categorized into VS bowing to the RV with its curvature ratio as <1.60, 1.60-<1.90, ≥1.90, respectively; and the fourth group with VS straight or bowing to the LV. Using a VS curvature ratio <1.60 as the reference, patients with higher VS curvature ratios had an increased risk of deterioration (odds ratio: 22.94 for ≥1.90 and 22.95 for VS straight & bowing to the LV). The VS curvature ratio demonstrated good discrimination for deterioration, with an AUC of 0.83 in the three local centers and 0.84 in the two non-local centers (280 patients). Conclusions: The VS curvature ratio, derived from CTPA images, is a promising image marker for predicting deterioration in normotensive acute PE patients.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA1372
Ventricular Septum Curvature Ratio: A Novel Imaging Marker to Predict Clinical Deterioration in Normotensive Acute Pulmonary Embolism
Background: Identifying high-probability deterioration individuals at the time of admission remains a challenge in normotensive patients with acute pulmonary embolism (PE). Ventricular septum (VS) deviation, as observed on computed tomography pulmonary angiography (CTPA), has been associated with poor prognosis in acute PE patients. Methods: This prospective multicenter cohort study enrolled normotensive patients with acute PE across five centers in China between January 2021 and June 2024. The VS and left ventricle (LV) free-wall curvature radii were measured using CTPA, and the VS curvature ratio was calculated and categorized. The endpoint was the occurrence of clinical deterioration event within 30 days after admission. The relationship between the VS curvature ratio and deterioration was analyzed using hierarchical logistic regression. The efficacy of identifying deterioration was assessed using the area under the receiver operating characteristic curve (AUC). Results: Of 3,310 patients, 272 (8.2%) experienced deterioration. In 3,030 patients from three centres, VS were categorized into VS bowing to the RV with its curvature ratio as <1.60, 1.60-<1.90, ≥1.90, respectively; and the fourth group with VS straight or bowing to the LV. Using a VS curvature ratio <1.60 as the reference, patients with higher VS curvature ratios had an increased risk of deterioration (odds ratio: 22.94 for ≥1.90 and 22.95 for VS straight & bowing to the LV). The VS curvature ratio demonstrated good discrimination for deterioration, with an AUC of 0.83 in the three local centers and 0.84 in the two non-local centers (280 patients). Conclusions: The VS curvature ratio, derived from CTPA images, is a promising image marker for predicting deterioration in normotensive acute PE patients.
- 5 March 2026
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 121 (3) , 555-572
Brain natriuretic peptide protects against acute pulmonary embolism-induced pulmonary vasoconstriction through natriuretic peptide receptor C
Acute pulmonary embolism (PE) remains a leading cause of cardiovascular mortality, driven primarily by a sudden increase in pulmonary artery (PA) resistance. Brain Natriuretic Peptide (BNP) may hold promise for reducing PA resistance. However, its role and mechanism in acute PE are not yet fully understood. This study aims to determine whether BNP alleviates PE-induced pulmonary vasoconstriction by targeting Natriuretic Peptide Receptor C (NPRC) and evaluate its therapeutic potential. Here, we established an acute PE rat model using autologous thrombi, and right ventricle (RV) pressure was monitored to approximate PA resistance. A small group of intermediate–high-risk acute PE patients were observed, who received BNP in addition to anticoagulation, and their clinical outcomes were compared to matched patients receiving anticoagulation alone. BNP at varying doses was administered to optimize therapeutic efficacy in the acute PE rat model. Mechanistic studies assessed BNP’s impact on oxidative stress in PA endothelium. In the rats, BNP infusion significantly reduced RV pressure overload and improved survival. Clinically, patients receiving adjunctive BNP experienced more rapid improvement in heart rate, oxygen saturation, and blood pressure stability than anticoagulation alone. BNP decreased NADPH oxidase 2-dependent ROS levels in rats’ PA endothelium, thereby reducing myosin light chain phosphorylation in smooth muscle. NPRC, as the central receptor, antagonizes the protective effect of BNP. Collectively, BNP offers a novel choice to mitigate PE-induced pulmonary vasoconstriction via NPRC-mediated mechanisms, which support BNP’s therapeutic potential for intermediate–high-risk PE.
- 5 March 2026
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 121 (3) , 555-572
Brain natriuretic peptide protects against acute pulmonary embolism-induced pulmonary vasoconstriction through natriuretic peptide receptor C
Acute pulmonary embolism (PE) remains a leading cause of cardiovascular mortality, driven primarily by a sudden increase in pulmonary artery (PA) resistance. Brain Natriuretic Peptide (BNP) may hold promise for reducing PA resistance. However, its role and mechanism in acute PE are not yet fully understood. This study aims to determine whether BNP alleviates PE-induced pulmonary vasoconstriction by targeting Natriuretic Peptide Receptor C (NPRC) and evaluate its therapeutic potential. Here, we established an acute PE rat model using autologous thrombi, and right ventricle (RV) pressure was monitored to approximate PA resistance. A small group of intermediate–high-risk acute PE patients were observed, who received BNP in addition to anticoagulation, and their clinical outcomes were compared to matched patients receiving anticoagulation alone. BNP at varying doses was administered to optimize therapeutic efficacy in the acute PE rat model. Mechanistic studies assessed BNP’s impact on oxidative stress in PA endothelium. In the rats, BNP infusion significantly reduced RV pressure overload and improved survival. Clinically, patients receiving adjunctive BNP experienced more rapid improvement in heart rate, oxygen saturation, and blood pressure stability than anticoagulation alone. BNP decreased NADPH oxidase 2-dependent ROS levels in rats’ PA endothelium, thereby reducing myosin light chain phosphorylation in smooth muscle. NPRC, as the central receptor, antagonizes the protective effect of BNP. Collectively, BNP offers a novel choice to mitigate PE-induced pulmonary vasoconstriction via NPRC-mediated mechanisms, which support BNP’s therapeutic potential for intermediate–high-risk PE.
- 19 February 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 67 (4) , 2502124
Performance of the Multimarker Calculator for predicting short-term deterioration and mortality in a Chinese prospective multicentre pulmonary embolism cohort
- 19 February 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 67 (4) , 2502124
Performance of the Multimarker Calculator for predicting short-term deterioration and mortality in a Chinese prospective multicentre pulmonary embolism cohort
- Open Access
- 31 October 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-10
Ventricular septum curvature ratio: a novel imaging marker to predict clinical deterioration in normotensive acute pulmonary embolism
Identifying high-probability deterioration individuals at the time of admission remains a challenge in normotensive patients with acute pulmonary embolism (PE). Ventricular septum (VS) deviation, as observed on computed tomography pulmonary angiography (CTPA), has been associated with poor prognosis in acute PE patients. However, the quantitative relationship between the VS curvature ratio and clinical deterioration in normotensive acute PE patients has not been fully explored. This study aimed to investigate the role of the VS curvature ratio derived from CTPA as an image marker for deterioration in normotensive acute PE patients. This prospective multicenter cohort study enrolled normotensive patients with acute PE across five centers in China between January 2021 and June 2024. The VS and left ventricle (LV) free-wall curvature radii were measured using CTPA, and the VS curvature ratio was calculated and categorized. The endpoint was the occurrence of clinical deterioration event within 30 days after admission. The relationship between the VS curvature ratio and deterioration was analyzed using hierarchical logistic regression. The efficacy of identifying deterioration was assessed using the area under the receiver operating characteristic curve (AUC). Of 3,310 patients, 272 (8.2%) experienced deterioration. In 3,030 patients from three centres, VS were categorized into four groups: VS bowing to the RV with its curvature ratio as < 1.60, 1.60-<1.90, ≥ 1.90, respectively; and the fourth group with VS straight or bowing to the LV. Using a VS curvature ratio < 1.60 as the reference, patients with higher VS curvature ratios had an increased risk of deterioration (odds ratio: 22.94 for ≥ 1.90 and 22.95 for VS straight & bowing to the LV, both p < 0.05). The VS curvature ratio demonstrated good discrimination for deterioration, with an AUC of 0.83 in the three local centers and 0.84 in the two non-local centers (280 patients). The VS curvature ratio, derived from CTPA images, is a promising image marker for predicting deterioration in normotensive acute PE patients. This study highlights the potential clinical impact of VS curvature ratio to identify normotensive PE patients at increased risk of deterioration and to adjust management strategies accordingly. ClinicalTrials.gov identifier: NCT05098769, October 16,2021, retrospectively registered.
- 31 October 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-10
Open AccessVentricular septum curvature ratio: a novel imaging marker to predict clinical deterioration in normotensive acute pulmonary embolism
Identifying high-probability deterioration individuals at the time of admission remains a challenge in normotensive patients with acute pulmonary embolism (PE). Ventricular septum (VS) deviation, as observed on computed tomography pulmonary angiography (CTPA), has been associated with poor prognosis in acute PE patients. However, the quantitative relationship between the VS curvature ratio and clinical deterioration in normotensive acute PE patients has not been fully explored. This study aimed to investigate the role of the VS curvature ratio derived from CTPA as an image marker for deterioration in normotensive acute PE patients. This prospective multicenter cohort study enrolled normotensive patients with acute PE across five centers in China between January 2021 and June 2024. The VS and left ventricle (LV) free-wall curvature radii were measured using CTPA, and the VS curvature ratio was calculated and categorized. The endpoint was the occurrence of clinical deterioration event within 30 days after admission. The relationship between the VS curvature ratio and deterioration was analyzed using hierarchical logistic regression. The efficacy of identifying deterioration was assessed using the area under the receiver operating characteristic curve (AUC). Of 3,310 patients, 272 (8.2%) experienced deterioration. In 3,030 patients from three centres, VS were categorized into four groups: VS bowing to the RV with its curvature ratio as < 1.60, 1.60-<1.90, ≥ 1.90, respectively; and the fourth group with VS straight or bowing to the LV. Using a VS curvature ratio < 1.60 as the reference, patients with higher VS curvature ratios had an increased risk of deterioration (odds ratio: 22.94 for ≥ 1.90 and 22.95 for VS straight & bowing to the LV, both p < 0.05). The VS curvature ratio demonstrated good discrimination for deterioration, with an AUC of 0.83 in the three local centers and 0.84 in the two non-local centers (280 patients). The VS curvature ratio, derived from CTPA images, is a promising image marker for predicting deterioration in normotensive acute PE patients. This study highlights the potential clinical impact of VS curvature ratio to identify normotensive PE patients at increased risk of deterioration and to adjust management strategies accordingly. ClinicalTrials.gov identifier: NCT05098769, October 16,2021, retrospectively registered.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e038984
Predicting Deterioration in Patients With Normotensive Acute Pulmonary Embolism Using Clinical‐Imaging Features: A Multicenter Prospective Cohort Study
Background: Prioritization of management strategies in patients with normotensive acute pulmonary embolism is based on the identification of individuals at risk for early deterioration. This study aims to develop and validate a novel score for deterioration prediction using clinical‐imaging features. Methods: This is multicenter, prospective observational cohort study (AOAPECT [Adverse Outcomes in Acute Pulmonary Embolism patients using Computed Tomography pulmonary angiography] cohort, NCT05098769). Registered‐enrolled patients with normotensive acute pulmonary embolism were collected consecutively from 5 centers across China. Derivation set was established from 2 centers, while local and nonlocal external validation sets were derived from the remaining 3 centers. The end point was pulmonary embolism‐related deterioration within 30 days after admission. Deterioration‐related candidate predictors consisted of clinical, laboratory and computed tomography pulmonary angiography parameters were screened and then split into dichotomous values. The predictive score was conducted by a multivariable logistics regression and validated. Score performances were quantified using the area under the receiver operating characteristic curve. Results: Of 3310 enrolled patients including 1 derivation (n=2061) and 2 validation sets (n=969 and 280), 272 patients (8.2%) experienced deterioration. In the derivation set, an increased risk of deterioration was observed with right to left ventricle diameter ratio ≥1.2, appearance of pulmonary vein sign on computed tomography pulmonary angiography, and heart rate ≥110 beats/min. When at least 2 out of 3 items were positive, patients were assigned to the high‐risk deterioration group. This PE‐RPH score revealed good discrimination to deterioration in derivation and validation sets (area under the receiver operating characteristic curve, 0.82, 0.82, and 0.80). Conclusions: This PE‐RPH score incorporating 2 computed tomography pulmonary angiography parameters and heart rate may help predict the deterioration risk in patients with normotensive acute pulmonary embolism. REGISTRATION: https://clinicaltrials.gov ; identifier: NCT05098769.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e038984
Open AccessPredicting Deterioration in Patients With Normotensive Acute Pulmonary Embolism Using Clinical‐Imaging Features: A Multicenter Prospective Cohort Study
Background: Prioritization of management strategies in patients with normotensive acute pulmonary embolism is based on the identification of individuals at risk for early deterioration. This study aims to develop and validate a novel score for deterioration prediction using clinical‐imaging features. Methods: This is multicenter, prospective observational cohort study (AOAPECT [Adverse Outcomes in Acute Pulmonary Embolism patients using Computed Tomography pulmonary angiography] cohort, NCT05098769). Registered‐enrolled patients with normotensive acute pulmonary embolism were collected consecutively from 5 centers across China. Derivation set was established from 2 centers, while local and nonlocal external validation sets were derived from the remaining 3 centers. The end point was pulmonary embolism‐related deterioration within 30 days after admission. Deterioration‐related candidate predictors consisted of clinical, laboratory and computed tomography pulmonary angiography parameters were screened and then split into dichotomous values. The predictive score was conducted by a multivariable logistics regression and validated. Score performances were quantified using the area under the receiver operating characteristic curve. Results: Of 3310 enrolled patients including 1 derivation (n=2061) and 2 validation sets (n=969 and 280), 272 patients (8.2%) experienced deterioration. In the derivation set, an increased risk of deterioration was observed with right to left ventricle diameter ratio ≥1.2, appearance of pulmonary vein sign on computed tomography pulmonary angiography, and heart rate ≥110 beats/min. When at least 2 out of 3 items were positive, patients were assigned to the high‐risk deterioration group. This PE‐RPH score revealed good discrimination to deterioration in derivation and validation sets (area under the receiver operating characteristic curve, 0.82, 0.82, and 0.80). Conclusions: This PE‐RPH score incorporating 2 computed tomography pulmonary angiography parameters and heart rate may help predict the deterioration risk in patients with normotensive acute pulmonary embolism. REGISTRATION: https://clinicaltrials.gov ; identifier: NCT05098769.
- 20 December 2022
- Published by Wiley in Environmental Toxicology
- Vol. 38 (4) , 754-769
JMJD3 downregulates IL4i1 aggravating lipopolysaccharide‐induced acute lung injury via H3K27 and H3K4 demethylation
The pro‐inflammation M1 to anti‐inflammation M2 macrophage ratio contribute to the severity of lipopolysaccharide (LPS)‐induced acute lung injury (ALI). JMJD3 aggravates the inflammatory reaction through affecting epigenetic modification and macrophage's phenotype to deteriorate ALI. To explore the mechanism underlying the upregulation of the macrophage M1/M2 ratio through JMJD3, we developed an ALI mouse model using intratracheal LPS, LPS‐stimulated RAW 264.7 cells, and inhibited JMJD3 using GSK‐J4. H3K27me3 and H3K4me3 were investigated as JMJD3‐mediated epigenetic alteration sites in vivo and in vitro. C/EBPβ and KDM5A were validated as linking factors between H3K27 and H3K4. IL4i1 was investigated as a JMJD3‐mediated targeted gene to regulate the macrophage M1/M2 ratio. Chromatin immunoprecipitation was used to evaluate the relationship between H3K27me3 and C/ebpβ , C/EBPβ and Kdm5a , H3K4me3 and Il4i1 . Inhibiting JMJD3 with GSK‐J4 can relieve inflammation and pathological performance in ALI. JMJD3 can reduce IL4i1 expression to increase the macrophage M1/M2 ratio and aggravated ALI which process was mediated via JMJD3‐indcued H3K27me3 and H3K4me3 demethylation, latter H3K4me3 demethylation inhibited IL4i1 transcription. Inhibiting JMJD3 with GSK‐J4 can increase IL4i1 expression, subsequently decreasing the expressions of M1 and increasing of M2 in vivo. The over‐expression IL4i1 in LPS‐stimulated macrophage or inhibiting JMJD3 with GSK‐J4 can both reverse the increase of the macrophage M1/M2 ratio in vitro. C/EBPβ and KDM5A were upregulated by LPS simulation, which linked JMJD3‐induced H3K27‐H3K4 demethylation. JMJD3 inhibited IL4i1 to increase the macrophage M1/M2 phenotype ratio and aggravate LPS‐induced ALI. Using GSK‐J4 to inhibit JMJD3 may facilitate the treatment of LPS‐induced ALI.
- 20 December 2022
- Published by Wiley in Environmental Toxicology
- Vol. 38 (4) , 754-769
JMJD3 downregulates IL4i1 aggravating lipopolysaccharide‐induced acute lung injury via H3K27 and H3K4 demethylation
The pro‐inflammation M1 to anti‐inflammation M2 macrophage ratio contribute to the severity of lipopolysaccharide (LPS)‐induced acute lung injury (ALI). JMJD3 aggravates the inflammatory reaction through affecting epigenetic modification and macrophage's phenotype to deteriorate ALI. To explore the mechanism underlying the upregulation of the macrophage M1/M2 ratio through JMJD3, we developed an ALI mouse model using intratracheal LPS, LPS‐stimulated RAW 264.7 cells, and inhibited JMJD3 using GSK‐J4. H3K27me3 and H3K4me3 were investigated as JMJD3‐mediated epigenetic alteration sites in vivo and in vitro. C/EBPβ and KDM5A were validated as linking factors between H3K27 and H3K4. IL4i1 was investigated as a JMJD3‐mediated targeted gene to regulate the macrophage M1/M2 ratio. Chromatin immunoprecipitation was used to evaluate the relationship between H3K27me3 and C/ebpβ , C/EBPβ and Kdm5a , H3K4me3 and Il4i1 . Inhibiting JMJD3 with GSK‐J4 can relieve inflammation and pathological performance in ALI. JMJD3 can reduce IL4i1 expression to increase the macrophage M1/M2 ratio and aggravated ALI which process was mediated via JMJD3‐indcued H3K27me3 and H3K4me3 demethylation, latter H3K4me3 demethylation inhibited IL4i1 transcription. Inhibiting JMJD3 with GSK‐J4 can increase IL4i1 expression, subsequently decreasing the expressions of M1 and increasing of M2 in vivo. The over‐expression IL4i1 in LPS‐stimulated macrophage or inhibiting JMJD3 with GSK‐J4 can both reverse the increase of the macrophage M1/M2 ratio in vitro. C/EBPβ and KDM5A were upregulated by LPS simulation, which linked JMJD3‐induced H3K27‐H3K4 demethylation. JMJD3 inhibited IL4i1 to increase the macrophage M1/M2 phenotype ratio and aggravate LPS‐induced ALI. Using GSK‐J4 to inhibit JMJD3 may facilitate the treatment of LPS‐induced ALI.
- Open Access
- 1 December 2022
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-10
H3K27 tri-demethylase JMJD3 inhibits macrophage apoptosis by promoting ADORA2A in lipopolysaccharide-induced acute lung injury
Acute lung injury (ALI) is a common critical disease, which is characterized by an uncontrolled, acute inflammatory response, diffuse lung damage and ultimately directly deteriorates into acute respiratory distress syndrome. The number of pro-inflammatory macrophages is related to the severity of ALI. Up-regulation of lipopolysaccharide (LPS)-activated macrophage apoptosis can reduce the pro-inflammatory reactions. Jumonji domain-containing protein D3 (JMJD3)-mediated histone 3 lysine 27 trimethylation (H3K27me3) demethylation may promote the pro-inflammatory response of macrophages under LPS stimulation. However, the mechanism of JMJD3 affecting macrophage apoptosis is still not clear. To explore this gap in knowledge, the ALI mice model with intratracheal administration of LPS and RAW264.7 cells with LPS stimulation were used as in vivo and in vitro experiments. The expression of JMJD3 and H3K27me3 and their cellular localization were analysed in lung tissue. Apoptosis was evaluated using TUNEL staining and flow cytometry. Expression of H3K27me3, ADORA2A and C/EBPβ were compared among different treatments and chromatin immunoprecipitation was performed to investigate the regulatory relationship. Our study showed that JMJD3 expression was upregulated in LPS-induced ALI mice and RAW264.7 cells. JMJD3-indued H3K27me3 demethylation inhibited caspase-3 cleavage by upregulating ADORA2A to decrease LPS-stimulated macrophage apoptosis and promoted the inflammatory reaction. This H3K27me3 demethylation also increased C/EBPβ expression, which may enhance ADORA2A expression further. Besides, inhibiting ADORA2A can also promote LPS-limited macrophage apoptosis. Moreover, the inhibition of JMJD3 in vivo and in vitro relieved the inhibition of macrophage apoptosis thus leading to the resolution of the inflammation. JMJD3 might inhibit macrophage apoptosis by promoting ADORA2A expression in LPS-induced ALI.
- 1 December 2022
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-10
Open AccessH3K27 tri-demethylase JMJD3 inhibits macrophage apoptosis by promoting ADORA2A in lipopolysaccharide-induced acute lung injury
Acute lung injury (ALI) is a common critical disease, which is characterized by an uncontrolled, acute inflammatory response, diffuse lung damage and ultimately directly deteriorates into acute respiratory distress syndrome. The number of pro-inflammatory macrophages is related to the severity of ALI. Up-regulation of lipopolysaccharide (LPS)-activated macrophage apoptosis can reduce the pro-inflammatory reactions. Jumonji domain-containing protein D3 (JMJD3)-mediated histone 3 lysine 27 trimethylation (H3K27me3) demethylation may promote the pro-inflammatory response of macrophages under LPS stimulation. However, the mechanism of JMJD3 affecting macrophage apoptosis is still not clear. To explore this gap in knowledge, the ALI mice model with intratracheal administration of LPS and RAW264.7 cells with LPS stimulation were used as in vivo and in vitro experiments. The expression of JMJD3 and H3K27me3 and their cellular localization were analysed in lung tissue. Apoptosis was evaluated using TUNEL staining and flow cytometry. Expression of H3K27me3, ADORA2A and C/EBPβ were compared among different treatments and chromatin immunoprecipitation was performed to investigate the regulatory relationship. Our study showed that JMJD3 expression was upregulated in LPS-induced ALI mice and RAW264.7 cells. JMJD3-indued H3K27me3 demethylation inhibited caspase-3 cleavage by upregulating ADORA2A to decrease LPS-stimulated macrophage apoptosis and promoted the inflammatory reaction. This H3K27me3 demethylation also increased C/EBPβ expression, which may enhance ADORA2A expression further. Besides, inhibiting ADORA2A can also promote LPS-limited macrophage apoptosis. Moreover, the inhibition of JMJD3 in vivo and in vitro relieved the inhibition of macrophage apoptosis thus leading to the resolution of the inflammation. JMJD3 might inhibit macrophage apoptosis by promoting ADORA2A expression in LPS-induced ALI.
- Open Access
- 15 April 2022
- Published by Springer Nature in BMC Medical Education
- Vol. 22 (1) , 1-7
Development of a career questionnaire for medical undergraduates using Mokken scale analysis
Background: Individual-centred career questionnaires are important for understanding the motivations of medical students. This study aimed to collect validity evidence of a questionnaire to measure the career choice of medical undergraduates. Methods: A cross-sectional survey was sent to third-year undergraduate students at a Chinese university-affiliated hospital. The questionnaire was formed using items that were selected after a systematic literature review. Item reduction was conducted using Mokken scale analysis, followed by reliability and validity testing, which described the validity evidence of the content, response process and internal structure. Results: The preliminary 20-item questionnaire was returned by 213 undergraduate students (response rate: 86.59%). To construct a monotone homogeneity model, 6 items were removed after testing for unidimensionality, local independence, and latent monotonicity according to the sequence. The final questionnaire included 14 items in two subscales: a 10-item ‘career advantage’ subscale and a 4-item ‘career disadvantage’ subscale. The questionnaire was judged to be acceptably reliable (Molenaar-Sijtsma method: 0.87 and 0.75, Cronbach’s alpha: 0.87 and 0.74) and to have good construct validity (χ2/df: 1.748, normed fit index: > 0.9, comparative fit index: > 0.9, root mean square error of approximation: 0.05–0.08). Male and female undergraduates had different responses regarding their salary, subspecialty, career prospects, and ability to serve their relatives. Male undergraduates might be more willing to accept on-call positions and have subspecialties with greater likelihoods of patient–physician conflict. Conclusion: We used Mokken scale analysis to develop and collect evidence of the validity of a 14-item questionnaire regarding career preferences among Chinese medical undergraduate students. This short and simple questionnaire may provide a suitable tool for exploring insights regarding the motivations of Chinese medical students.
- 15 April 2022
- Published by Springer Nature in BMC Medical Education
- Vol. 22 (1) , 1-7
Open AccessDevelopment of a career questionnaire for medical undergraduates using Mokken scale analysis
Background: Individual-centred career questionnaires are important for understanding the motivations of medical students. This study aimed to collect validity evidence of a questionnaire to measure the career choice of medical undergraduates. Methods: A cross-sectional survey was sent to third-year undergraduate students at a Chinese university-affiliated hospital. The questionnaire was formed using items that were selected after a systematic literature review. Item reduction was conducted using Mokken scale analysis, followed by reliability and validity testing, which described the validity evidence of the content, response process and internal structure. Results: The preliminary 20-item questionnaire was returned by 213 undergraduate students (response rate: 86.59%). To construct a monotone homogeneity model, 6 items were removed after testing for unidimensionality, local independence, and latent monotonicity according to the sequence. The final questionnaire included 14 items in two subscales: a 10-item ‘career advantage’ subscale and a 4-item ‘career disadvantage’ subscale. The questionnaire was judged to be acceptably reliable (Molenaar-Sijtsma method: 0.87 and 0.75, Cronbach’s alpha: 0.87 and 0.74) and to have good construct validity (χ2/df: 1.748, normed fit index: > 0.9, comparative fit index: > 0.9, root mean square error of approximation: 0.05–0.08). Male and female undergraduates had different responses regarding their salary, subspecialty, career prospects, and ability to serve their relatives. Male undergraduates might be more willing to accept on-call positions and have subspecialties with greater likelihoods of patient–physician conflict. Conclusion: We used Mokken scale analysis to develop and collect evidence of the validity of a 14-item questionnaire regarding career preferences among Chinese medical undergraduate students. This short and simple questionnaire may provide a suitable tool for exploring insights regarding the motivations of Chinese medical students.
- 1 August 2021
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 90, 116-118
Phenotyping of non-high-risk acute pulmonary embolism patients: different initial manifestations of clinical deterioration
- 1 August 2021
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 90, 116-118
Phenotyping of non-high-risk acute pulmonary embolism patients: different initial manifestations of clinical deterioration